Whitnell & Co’s Idexx Laboratories IDXX Stock Holding History

Whitnell & Co’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-270	Closed	-$12K	–	316
2013 Q2	$12K	Buy	+270	New	+$11.8K	0.01%	266

Other funds holding IDXX

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

RCG

Ruane, Cunniff & Goldfarb New York $6.43B AUM 18.44% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Whitnell & Co's IDXX Position: Q3 2013 in Review

Whitnell & Co sold out of Idexx Laboratories (IDXX) in Q3 2013, closing a stake of 270 shares — an estimated $12K sold.

Whitnell & Co first reported a position in IDXX in Q2 2013 and held it in 1 quarter. The position peaked at $12K in Q2 2013. 274 funds tracked by Wall St. Rank hold IDXX as of Q3 2013.

Whitnell & Co reported no remaining Idexx Laboratories position as of Q3 2013 after selling out during the quarter.
Whitnell & Co sold 270 Idexx Laboratories shares in Q3 2013, an estimated $12K.
Whitnell & Co first reported a position in Idexx Laboratories in Q2 2013 and held it in 1 quarter.
Whitnell & Co's Idexx Laboratories position peaked at $12K in Q2 2013.
274 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2013.

Based on Whitnell & Co's 13F filing for Q3 2013, filed 12 Nov 2013.